VVOS Vivos Therapeutics, Inc.
Fundamentals / CIK 0001716166 / USDVivos Therapeutics, Inc. reported $20.53M in revenue and a net loss of $22.00M for the trailing twelve months ended September 30, 2026 (down 5.4% year over year), with a 60.0% gross margin and a -105.8% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VVOS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$20.53M -5.4% YoY
-
Operating Income TTM-$21.72M -105.8% margin
-
Net Income TTM-$22.00M -107.2% net margin
-
Diluted EPS TTM-$0.83 Split-adjusted
-
Free Cash Flow TTM-$18.17M -88.5% FCF margin
-
Cash & ST Investments Sep 30, 2026$247K Total debt: $5.99M
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $17.44M | $15.03M | $13.80M | $16.02M | $16.89M | $13.07M | $11.39M |
| Cost of Revenue | $6.90M | $6.01M | $5.53M | $200K | $400K | $100K | $2.74M |
| Gross Profit | $10.54M | $9.02M | $8.27M | $10.02M | $12.60M | $10.41M | $8.66M |
| Research & Development | $100K | $100K | $100K | $200K | $200K | -- | -- |
| Selling, General & Admin | $29.13M | $19.61M | $24.95M | $34.38M | $31.34M | $18.40M | $18.48M |
| Total Operating Expenses | $30.44M | $20.19M | $25.57M | $35.05M | $32.99M | $22.45M | $19.23M |
| Operating Income | -$19.89M | -$11.17M | -$17.30M | -$25.03M | -$20.38M | -$12.04M | -$10.58M |
| EBITDA | -$18.59M | -$10.59M | -$16.68M | -$24.36M | -$19.65M | -$11.32M | -$9.83M |
| Interest Income | -- | -- | -- | -- | $117K | $79K | $21K |
| Interest Expense | $1.40M | -- | -- | -- | $14K | $96K | $138K |
| Income Before Tax | -$21.23M | -$11.14M | -$13.58M | -$23.84M | -$20.29M | -$12.06M | -$10.75M |
| Net Income | -$21.17M | -$11.14M | -$13.58M | -$23.84M | -$20.29M | -$12.06M | -$10.75M |
| Basic EPS | -$2.07 | -$2.22 | -$11.14 | -$647.50 | -$24.00 | -$35.00 | -$23.75 |
| Diluted EPS | -$2.07 | -$2.22 | -$11.14 | -$647.50 | -$24.00 | -$35.00 | -$23.75 |
| Basic Shares Outstanding | 10.3M | 5.0M | 1.2M | 36.8K | 849.3M | 514.8K | 493.3K |
| Diluted Shares Outstanding | 10.3M | 5.0M | 1.2M | 36.8K | 849.3K | 514.8K | 493.3K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.41M | $5.15M | $5.14M | $3.82M | $6.78M | $3.82M | $3.02M | $3.70M |
| Cost of Revenue | $3.10M | $2.20M | $2.08M | $836K | $2.85M | $1.71M | $1.51M | $1.60M |
| Gross Profit | $3.31M | $2.95M | $3.06M | $2.99M | $3.94M | $2.11M | $1.51M | $2.10M |
| Selling, General & Admin | $6.66M | $7.27M | $9.22M | $8.93M | $8.29M | $6.67M | $5.25M | $4.76M |
| Total Operating Expenses | $7.21M | $7.78M | $9.67M | $9.37M | $8.67M | $6.97M | $5.43M | $4.90M |
| Operating Income | -$3.90M | -$4.83M | -$6.62M | -$6.38M | -$4.73M | -$4.87M | -$3.92M | -$2.81M |
| EBITDA | -$3.35M | -$4.32M | -$6.16M | -$5.94M | -$4.35M | -$4.56M | -$3.74M | -$2.66M |
| Interest Expense | $600K | $1.10M | $1.10M | -- | $500K | -- | -- | -- |
| Income Before Tax | -$1.97M | -$5.52M | -$7.75M | -$6.95M | -$5.40M | -$5.01M | -$3.86M | -$2.83M |
| Net Income | -$1.95M | -$5.48M | -$7.68M | -$6.89M | -$5.40M | -$5.01M | -$3.86M | -$2.83M |
| Basic EPS | -$0.07 | -$0.31 | -$0.52 | -- | -$0.49 | -$0.55 | -$0.45 | -- |
| Diluted EPS | -$0.07 | -$0.31 | -$0.52 | -- | -$0.49 | -$0.55 | -$0.45 | -- |
| Basic Shares Outstanding | 26.5M | 17.7M | 14.6M | -- | 11.0M | 9.1M | 8.6M | -- |
| Diluted Shares Outstanding | 26.5M | 17.7M | 14.6M | -- | 11.0M | 9.1M | 8.6M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $2.03M | $6.26M | $1.64M | $3.52M | $24.03M | $18.21M | $469K |
| Cash & Short-Term Investments | $2.03M | $6.26M | $1.64M | $3.52M | $24.03M | $18.21M | $469K |
| Accounts Receivable, Net | $1.58M | $430K | $202K | $457K | $1.20M | $1.43M | $871K |
| Total Current Assets | $4.38M | $7.47M | $2.46M | $5.42M | $27.32M | $20.39M | $1.98M |
| Property, Plant & Equipment, Net | $3.76M | $3.31M | $3.31M | $3.08M | $2.83M | $872K | $1.14M |
| Goodwill | $8.57M | $2.84M | $2.84M | $2.84M | $2.84M | $2.67M | $2.67M |
| Intangible Assets | $4.04M | $409K | $420K | $302K | $341K | $270K | $689K |
| Total Non-Current Assets | $20.77M | $7.81M | $8.27M | $8.30M | $6.37M | $4.93M | $5.57M |
| Total Assets | $25.15M | $15.28M | $10.73M | $13.72M | $33.69M | $25.33M | $7.55M |
| Accounts Payable | $1.68M | $1.10M | $2.15M | $1.41M | $920K | $781K | $1.08M |
| Short-Term Debt | $8.35M | -- | -- | -- | $1.26M | $867K | $3.71M |
| Deferred Revenue (Current) | $479K | $896K | $2.14M | $2.93M | $2.40M | $2.94M | $2.95M |
| Other Current Liabilities | $850K | $273K | $198K | $145K | -- | -- | -- |
| Total Current Liabilities | $18.08M | $4.98M | $7.29M | $6.81M | $7.51M | $7.84M | $9.09M |
| Long-Term Debt | $469K | $1.20M | $1.20M | -- | $0 | $423K | $0 |
| Deferred Revenue (Non-Current) | -- | $97K | $289K | $112K | -- | -- | -- |
| Other Non-Current Liabilities | $1.30M | -- | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $8.63M | $2.35M | $3.03M | $2.11M | $641K | $569K | $84K |
| Total Liabilities | $26.70M | $7.33M | $10.32M | $8.92M | $8.15M | $8.41M | $9.18M |
| Total Debt (incl. Leases) | $13.50M | $2.71M | $3.19M | $2.41M | $1.98M | $1.29M | $3.71M |
| Common Stock | $1.0K | -- | -- | $2.0K | $2.0K | $2.0K | $1.2K |
| Retained Earnings | -$125.4M | -$104.2M | -$93.05M | -$79.47M | -$55.62M | -$35.34M | -$23.28M |
| Total Stockholders' Equity | -$1.49M | $7.95M | $411K | $4.80M | $25.54M | $16.92M | -$2.94M |
| Total Equity | -$1.55M | $7.95M | $411K | $4.80M | $25.54M | $16.92M | -$2.94M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $247K | $1.77M | $2.11M | $2.03M | $3.09M | $4.40M | $2.34M | $6.26M |
| Cash & Short-Term Investments | $247K | $1.77M | $2.11M | $2.03M | $3.09M | $4.40M | $2.34M | $6.26M |
| Accounts Receivable, Net | $2.37M | $1.44M | $1.77M | $1.58M | $2.13M | $1.63M | $718K | $430K |
| Total Current Assets | $3.51M | $4.21M | $4.82M | $4.38M | $5.79M | $6.73M | $3.61M | $7.47M |
| Property, Plant & Equipment, Net | $3.35M | $3.64M | $3.53M | $3.76M | $5.64M | $5.13M | $3.31M | $3.31M |
| Goodwill | $8.57M | $8.57M | $8.57M | $8.57M | $8.45M | $8.45M | $2.84M | $2.84M |
| Intangible Assets | $3.44M | $3.64M | $3.84M | $4.04M | $2.17M | $2.23M | $358K | $409K |
| Total Non-Current Assets | $19.35M | $19.93M | $20.22M | $20.77M | $19.86M | $19.30M | $7.67M | $7.81M |
| Total Assets | $22.86M | $24.14M | $25.04M | $25.15M | $25.64M | $26.03M | $11.28M | $15.28M |
| Accounts Payable | $2.74M | $2.95M | $2.00M | $1.68M | $2.10M | $1.76M | $1.21M | $1.10M |
| Short-Term Debt | $1.50M | $7.77M | $7.30M | $8.35M | $339K | $157K | -- | -- |
| Deferred Revenue (Current) | $72K | $583K | $495K | $479K | $537K | $480K | $572K | $896K |
| Other Current Liabilities | $2.12M | $1.20M | $1.23M | $850K | $987K | $1.01M | $672K | $273K |
| Total Current Liabilities | $16.16M | $20.39M | $17.94M | $18.08M | $7.44M | $6.43M | $4.70M | $4.98M |
| Long-Term Debt | $313K | $366K | $418K | $469K | $8.38M | $7.76M | -- | $1.20M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | $1.0K | $5.0K | $22K | $97K |
| Other Non-Current Liabilities | $950K | $950K | $1.30M | $1.30M | $1.40M | $1.40M | -- | -- |
| Total Non-Current Liabilities | $4.53M | $7.74M | $8.37M | $8.63M | $15.68M | $15.02M | $2.17M | $2.35M |
| Total Liabilities | $20.69M | $28.13M | $26.31M | $26.70M | $23.11M | $21.45M | $6.88M | $7.33M |
| Total Debt (incl. Leases) | $5.99M | $12.51M | $12.27M | $13.50M | $12.50M | $11.58M | $1.40M | $2.71M |
| Common Stock | $3.0K | $1.0K | $1.0K | $1.0K | $1.0K | -- | -- | -- |
| Retained Earnings | -$140.5M | -$138.5M | -$133.0M | -$125.4M | -$118.5M | -$113.1M | -$108.1M | -$104.2M |
| Total Stockholders' Equity | $2.36M | -$3.81M | -$1.14M | -$1.49M | $2.53M | $4.58M | $4.41M | $7.95M |
| Total Equity | $2.16M | -$3.99M | -$1.27M | -$1.55M | $2.53M | $4.58M | $4.41M | $7.95M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$21.23M | -$11.14M | -$13.58M | -$23.84M | -$20.29M | -$12.06M | -$10.75M |
| Depreciation & Amortization | $1.31M | $581K | $621K | $669K | $733K | $718K | $751K |
| Stock-Based Compensation | $661K | $762K | $1.11M | $2.40M | $2.66M | $2.17M | $1.99M |
| Change in Receivables | -$217K | -$228K | $255K | $746K | $228K | -$560K | -$276K |
| Change in Payables | $524K | -$1.05M | $734K | $491K | $139K | -$274K | $548K |
| Operating Cash Flow | -$15.26M | -$12.69M | -$11.95M | -$19.59M | -$15.73M | -$5.68M | -$5.34M |
| Capital Expenditure | -$2.34M | -$568K | -$803K | -$924K | -$2.40M | -$120K | -$176K |
| Free Cash Flow | -$17.60M | -$13.26M | -$12.75M | -$20.51M | -$18.13M | -$5.80M | -$5.52M |
| Acquisitions, Net | -- | -- | -- | -- | -$225K | -- | -- |
| Investing Cash Flow | -$7.53M | -$568K | -$853K | -$924K | -$2.61M | -$120K | $86K |
| Common Stock Issued | $5.58M | $7.80M | $4.00M | -- | $27.93M | $22.29M | $1.25M |
| Financing Cash Flow | $18.56M | $17.88M | $10.92M | -- | $24.17M | $23.54M | $4.47M |
| Net Change in Cash | -$4.23M | $4.62M | -$1.88M | -$20.51M | $5.82M | $17.74M | -$785K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.97M | -$5.52M | -$7.75M | -$6.95M | -$5.40M | -$5.01M | -$3.86M | -$2.83M |
| Depreciation & Amortization | $550K | $510K | $454K | $442K | $384K | $306K | $177K | $144K |
| Stock-Based Compensation | $76K | $50K | $151K | $47K | $55K | $242K | $317K | $57K |
| Change in Receivables | -$932K | $331K | -$188K | $553K | -$501K | $19K | -$288K | $24K |
| Change in Payables | -$208K | $950K | $318K | -$424K | $340K | $499K | $109K | $22K |
| Operating Cash Flow | -$3.18M | -$3.15M | -$6.01M | -$3.81M | -$4.16M | -$3.49M | -$3.80M | -$2.94M |
| Capital Expenditure | -$61K | -$416K | -$18K | -$1.53M | $83K | -$771K | -$122K | -$165K |
| Free Cash Flow | -$3.24M | -$3.56M | -$6.03M | -$5.34M | -$4.08M | -$4.26M | -$3.92M | -$3.10M |
| Investing Cash Flow | -$61K | -$416K | -$18K | -$1.58M | $83K | -$5.91M | -$122K | -$165K |
| Common Stock Issued | $302K | $291K | $342K | -- | -- | -- | -- | -- |
| Financing Cash Flow | $1.71M | $3.23M | $6.11M | -- | -- | -- | -- | $3.05M |
| Net Change in Cash | -$1.53M | -$336K | $81K | -$1.06M | -$1.31M | $2.06M | -$3.92M | -$51K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 60.4% | 60.0% | 59.9% | 62.5% | 74.6% | 79.7% | 76.0% |
| Operating Margin | -114.1% | -74.3% | -125.3% | -156.2% | -120.7% | -92.1% | -92.8% |
| Net Profit Margin | -121.4% | -74.1% | -98.4% | -148.8% | -120.2% | -92.3% | -94.4% |
| Return on Equity (ROE) | -- | -140.0% | -3304.9% | -496.7% | -79.4% | -71.3% | -- |
| Return on Assets (ROA) | -84.2% | -72.9% | -126.6% | -173.8% | -60.2% | -47.6% | -142.4% |
| Current Ratio | 0.24x | 1.50x | 0.34x | 0.80x | 3.64x | 2.60x | 0.22x |
| Quick Ratio | 0.20x | 1.34x | 0.25x | 0.58x | 3.36x | 2.50x | 0.15x |
| Debt to Equity | -- | 0.34x | 7.77x | 0.50x | 0.08x | 0.08x | -- |
| Revenue Growth (YoY) | +16.0% | +8.9% | -13.9% | -5.1% | +29.2% | +14.7% | -- |
| Gross Profit Growth (YoY) | +16.9% | +9.0% | -17.4% | -20.5% | +21.0% | +20.3% | -- |
| 5Y Revenue / Share Growth | -93.3% | -87.0% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.0% | 61.9% | 61.8% | 60.4% | 55.7% | 55.9% | 58.7% | 60.0% |
| Operating Margin | -105.8% | -107.9% | -115.5% | -114.1% | -94.3% | -98.9% | -77.3% | -74.3% |
| Net Profit Margin | -107.2% | -121.8% | -127.7% | -121.4% | -98.8% | -99.5% | -76.8% | -74.1% |
| Return on Equity (ROE) | -932.3% | -- | -- | -- | -675.5% | -312.5% | -255.0% | -140.0% |
| Return on Assets (ROA) | -96.3% | -105.4% | -99.8% | -84.2% | -66.7% | -55.0% | -99.6% | -72.9% |
| Current Ratio | 0.22x | 0.21x | 0.27x | 0.24x | 0.78x | 1.05x | 0.77x | 1.50x |
| Quick Ratio | 0.16x | 0.16x | 0.22x | 0.20x | 0.70x | 0.94x | 0.65x | 1.34x |
| Debt to Equity | 2.54x | -- | -- | -- | 4.94x | 2.53x | 0.32x | 0.34x |
| Revenue Growth (YoY) | -5.4% | +34.9% | +70.5% | +3.4% | +75.7% | -5.8% | -11.8% | +13.9% |
| Gross Profit Growth (YoY) | -15.8% | +40.0% | +102.7% | +42.5% | +68.7% | -20.4% | -22.1% | +0.4% |